ECA
TMO icon

Elevated Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Elevated Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
715
-494
-41% -$237K 0.1% 173
2026
Q1 		$594K Buy
1,209
+102
+9% +$55.4K 0.15% 158
2025
Q4 		$642K Sell
1,107
-235
-18% -$133K 0.15% 166
2025
Q3 		$651K Sell
1,342
-171
-11% -$79.6K 0.16% 169
2025
Q2 		$753K Hold
1,513
– – 0.21% 146
2025
Q1 		$753K Sell
1,513
-49
-3% -$26.5K 0.21% 146
2024
Q4 		$813K Buy
1,562
+11
+0.7% +$6.05K 0.22% 136
2024
Q3 		$959K Buy
1,551
+55
+4% +$32.6K 0.25% 113
2024
Q2 		$827K Buy
1,496
+124
+9% +$71K 0.23% 116
2024
Q1 		$797K Buy
1,372
+80
+6% +$44.9K 0.23% 107
2023
Q4 		$686K Buy
1,292
+153
+13% +$74.1K 0.21% 115
2023
Q3 		$577K Buy
1,139
+4
+0.4% +$2.13K 0.2% 114
2023
Q2 		$592K Buy
1,135
+80
+8% +$43.2K 0.2% 121
2023
Q1 		$608K Buy
1,055
+15
+1% +$8.45K 0.22% 114
2022
Q4 		$572K Sell
1,040
-1,642
-61% -$870K 0.22% 107
2022
Q3 		$1.36M Buy
+2,682
New +$1.5M 0.54% 62
2022
Q1 		$1.69M Buy
+2,853
New +$1.64M 0.56% 47
2021
Q3 		$1.68M Buy
+2,947
New +$1.62M 0.58% 46
2021
Q1 		$1.29M Buy
2,677
+162
+6% +$77.3K 0.5% 65
2020
Q4 		$1.17M Buy
2,515
+138
+6% +$64.7K 0.51% 57
2020
Q3 		$1.11M Sell
2,377
-455
-16% -$188K 0.52% 56
2020
Q2 		$1.25M Buy
+2,832
New +$949K 0.59% 52
2019
Q4 		$306K Buy
+942
New +$286K 0.34% 82
2019
Q1 		$681K Buy
+2,090
New +$520K 0.45% 82

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Elevated Capital Advisors's TMO Position: Q2 2026 in Review

Elevated Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 41% in Q2 2026, selling an estimated $237K and leaving 715 shares worth $359K. The position accounts for 0.1% of the portfolio, ranked #173.

Elevated Capital Advisors first reported a position in TMO in Q1 2019 and has held it in 24 quarters since. The position peaked at $1.69M in Q1 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Elevated Capital Advisors held 715 shares of Thermo Fisher Scientific worth $359K as of Q2 2026.
  • Elevated Capital Advisors sold 494 Thermo Fisher Scientific shares in Q2 2026, an estimated $237K.
  • Thermo Fisher Scientific made up 0.1% of Elevated Capital Advisors's portfolio in Q2 2026, its #173 holding.
  • Elevated Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 24 quarters since.
  • Elevated Capital Advisors's Thermo Fisher Scientific position peaked at $1.69M in Q1 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.